期刊文献+

临床分离肺炎克雷伯菌对碳青霉烯类药物的耐药性研究 被引量:6

STUDY ON CARBAPENEM RESISTANCE OF CLINICALLY ISOLATED KLEBSIELLA PNEUMONIAE
原文传递
导出
摘要 目的临床分离肺炎克雷伯菌对碳青霉烯类药物的耐药性变迁,为临床合理使用抗菌药物提供参考。方法通过临床标本细菌分离鉴定和药敏试验方法,对某医院2009-2012年临床送检标本病原学检验结果进行调查与分析。结果该医院连续4年从临床送检标本中共分离出肺炎克雷伯菌1 384株。2009-2012年每年分离的肺炎克雷伯菌对亚胺培南的敏感率分别为100%、99.1%、98.8%和92.8%,呈逐年下降趋势。检出10株耐碳青霉烯类药物的肺炎克雷伯菌对阿米卡星敏感率为90%,但对亚胺培南和庆大霉素敏感率分别为20%和10%,对其他类抗菌药物全部耐药。结论耐碳青霉烯类药物的肺炎克雷伯菌对多数种类抗菌药物敏感性逐年下降,易引起产酶克隆株播散流行。 Objective To analyze the changes of Carbapenem resistance of Klebsiella pneumoniae isolated from clinic so as to give some reference to clinical rational use of antibiotics. Methods The methods of bacterial isolation and identification and drug susceptibility test were used to investigate and analyze the results of pathogenic detection from clinical samples in a hospital during year 2009-2012. Results There were 1 384 strains of Klebsiella pneumoniae isolated from clinic samples continuously for 4 years in this hospital. Sensitive rate to Imipenem of Klebsiella pneumoniae isolated from year 2009-2012 were 100%,99. 1%,98. 8% and 92. 8% respectively with a declining trend. The sensitive rate to Amikacin of 10 strains of Carbapenem-resistant was the highest( 90%),followed by Imipenem( 20%) and Gentamicin( 10%),and the rest were 0. Conclusion The susceptibility of Carbapenem-resistant Klebsiella pneumoniae to many kinds of antibiotics is decreased yearly and can easily cause the epidemic of Carbapenemases strains in hospital.
出处 《中国消毒学杂志》 CAS 北大核心 2014年第5期473-475,共3页 Chinese Journal of Disinfection
关键词 肺炎克雷伯菌 碳青霉烯酶 耐药性 Klebsiella pneumoniae carbapenemases drug - resistance
  • 相关文献

参考文献11

  • 1谢奇恩,林福林,庞素秋.碳青霉烯类抗生素的研究进展[J].北方药学,2011,8(2):51-54. 被引量:25
  • 2CLSI. Performance standards for antimicrobial susceptibility tes- ting. Nineteenth informational supplement[ S]. 2010:38 - 139.
  • 3Piekarska K, Zacharczuk K, Szych J, et al. Dissemination of the KPC earbapeenaase producing Klebsiella pneumoniae in a hospi- tal in Warsaw, Poland[J]. Med Dosw Mikrobiol, 2010, 62( 1 ) : 9 - 20.
  • 4Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chro- mosomal DNA restriction patterns produced by pulsed -field gel electrophoresis: criteria tbr bacterial strain typing [ J ]. J Clin Microbiol, 1995,33 ( 9 ) : 2233 - 2239.
  • 5Queenan A M, Bush K. Carbapenemases: the versatile beta lac- tamases [ J]. Clin Microbiol Rev, 2007, 20 (3) : 440 - 458.
  • 6Oteo J, Delgado - lribarren A, Vega D, et al. Emergence of imipenem resistance in clinical Escherichia coli during therapy [J]. Int J Antimicrob Agents, 2008, 32(6) : 534 -537.
  • 7Wei ZQ,Du XX,Yu Ys,et al. Plasmid -mediated KPC -2 in a Klebsiella pneumoniae isolate from China[ J]. Antimierob Agents Chemother,2007,51 ( 2 ) :763 - 765.
  • 8苏丹虹,李敏亮,金光耀,卓超.肺炎克雷伯菌及大肠埃希菌产KPC酶的检测研究[J].中国抗生素杂志,2009,34(11):684-687. 被引量:18
  • 9李轶,冯羡菊.河南发现产KPC-2型碳青霉烯酶的肺炎克雷伯菌[J].中华检验医学杂志,2009,32(9):1045-1046. 被引量:10
  • 10胡付品,叶信予,吴培澄,吴湜,朱德妹,汪复.2005年上海华山医院细菌耐药性监测[J].中国感染与化疗杂志,2007,7(4):233-237. 被引量:58

二级参考文献52

共引文献105

同被引文献42

  • 1李松林,王进,刘远程,肖永红,王喆.临床分离铜绿假单胞菌对碳青霉烯类药物的耐药机制[J].中国临床药理学杂志,2007,23(2):137-140. 被引量:14
  • 2CLSI. M100-$24. Performance standards for antimicrobial susceptibility testing: Twenty-second informational sup- plement[S]. Wayne, PA, USA: CLSI, 2014.
  • 3van Duin D,Cober ED, Richter SS, et al. Tigeeycline ther- apy for earbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance[J].Clin Microbiol Infect,2014,20(12) :1117 -1120.
  • 4Brust K,Evans A, Piemmons R. Tigecycline in treatment of muhidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review [J]. J Antimicrob Chemother, 2014,69 (10) : 2606-2610.
  • 5Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing:22th in- formational supplement,M100-S22[S].2012.
  • 6Pappo-wallacekm,Endimiania,Taracila MA,et al.Cara- penems:Past,present and future[J].Antimcrob Agents Chemo-therapy,2011,55(11):4943-4960.
  • 7MacKenzie FM,Forbes KJ,Dorai-John T,et al.Emer- gence of a carbapenem-resistant Klebsiella pneumoniae[J].Lancet,1997,350(9080):783.
  • 8Arnold RS,Them KA,Sharma S,et al.Emergence of Kleb- siella pneumoniae carbapenemase-producing bacteria[J].South Med J,2011,104(1):4045.
  • 9Markogiannakis H,Pachylaki N,Samara E,et al.Infections in a surgical intensive care unit of an university hospital in Greece[J].Int J Infect Dis,2009,13:145-153.
  • 10Tharavichitkul P,Khantawa B,Bousoung V,Boonchoo M.Activity of fosfomycin against extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli in Maharaj Nakorn Chiang Mai Hospital[J].J Infect Dis Antimicrob Agents,2005,22:121-126.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部